R&D Costs and Amortization Insights
Uploaded by
Jannelle Salac- Chapter 22: Intangible Assets
- Additional Intangible Asset Problems
Common questions
Powered by AIDifferentiating between costs before and after technological feasibility is crucial as it determines which costs should be expensed immediately and which can be capitalized as assets. This distinction affects the timing and measurement of expenses and assets in financial statements, impacting short-term profitability and long-term asset valuation .
Prototype costs, including those for special equipment used solely for R&D or costs associated with producing and testing prototypes, are considered part of R&D expenses. These costs are expensed as incurred, reflecting the investment in experimental development and the uncertainty of the economic benefits associated with prototypes .
The straight-line method of amortization spreads the cost of an intangible asset evenly over its useful life, reflecting consistent usage and benefit from the asset. A revenue-based method is prohibited because it may not accurately reflect the actual periodic use or benefit derived from the intangible asset due to fluctuating revenue streams, leading to potential distortions in financial statements .
Costs related to duplication of software and packaging of training materials can be included in inventory when these materials are intended for sale. This classification is appropriate because these materials represent goods that will provide future revenues and match production costs with eventual income, aligning with inventory accounting principles .
Market research activities are expensed as selling costs because they are associated with understanding the market environment and customer needs, rather than directly contributing to the creation or development of a new product or technology. This classification aligns with the expense's functional nature and timing of benefits .
Research costs are typically expensed as incurred due to their uncertain future benefits, whereas development costs may be capitalized if certain criteria are met, such as technological feasibility and probable future economic benefits. Other costs, like market research activities, are expensed as selling costs .
Establishment of technological feasibility serves as a demarcation point where costs can be capitalized, indicating that the project has progressed beyond the research phase into development. It signifies a transition from costs that should be expensed to those that may provide future economic benefits and thus can be recognized as an asset .
Market research activity costs are expensed as selling costs, justified by their function of promoting and understanding the product market rather than directly developing new technologies or products. This treatment reflects the immediate benefit of these activities in driving sales and revenue, rather than future benefits .
Main elements of R&D expenses include costs such as design and modification of products and processes, depreciation of equipment used solely for R&D, salaries, materials, and indirect costs. These elements are significant as they provide a detailed understanding of a company's investment in innovation and future growth potential, impacting financial performance and valuation .
A company might choose to capitalize development costs after achieving technological feasibility because these costs represent a probable future economic benefit that meets asset recognition criteria. Capitalization impacts financial statements by increasing asset values and deferring expense recognition, which can improve apparent profitability and leverage for period and enhance asset management indicators .
